Rankings
▼
Calendar
RGEN
Repligen Corporation
$7B
Q4 2018 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$52M
+24.8% YoY
Gross Profit
$29M
55.7% margin
Operating Income
$8M
15.1% margin
Net Income
$6M
10.9% margin
EPS (Diluted)
$0.12
QoQ Revenue Growth
+4.9%
Cash Flow
Operating Cash Flow
$6M
Free Cash Flow
$98,000
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$139M
Total Liabilities
$159M
Stockholders' Equity
$616M
Cash & Equivalents
$194M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$52M
$42M
+24.8%
Gross Profit
$29M
$22M
+28.7%
Operating Income
$8M
$3M
+140.8%
Net Income
$6M
$12M
-53.7%
Revenue Segments
Product
$52M
100%
Royalty
$93,000
0%
← FY 2018
All Quarters
Q1 2019 →
RGEN Q4 2018 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena